17 results
The Pathway of Heme Synthesis, Showing Pathway Intermediates and End-Product Regulation by Heme #Pathophys #Honc #Heme
Intermediates and End-Product ... Heme #Pathophys #Honc ... Synthesis #Porphyria #NEJM
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
Dizziness #Diagnosis #PrimaryCare ... #EM #IM #Differential ... Lightheadedness #Table #NEJM
Paths to Defective Homologous Recombination DNA Repair in Breast Cancer. Each individual mutation or epigenetic aberration
DNA Repair in Breast ... common feature of breast ... cancer #Pathophys #Honc ... BreastCancer #DNARepair #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
Fracture #EBM #PrimaryCare ... #Endo #IM #Romosozumab ... #Alendronate #NEJM
Crusted Scabies - Physical examination now revealed a generalized erythematous and scaly rash with intense hyperkeratotic
, interdigital areas ... , and genital areas ... Clinical #Derm #PrimaryCare ... Scabies #Microscopy #NEJM
Panel A shows a patient with erythematotelangiectatic rosacea, in which diffuse erythema and telangiectasia are present
(i.e., convex areas ... Clinical #Derm #PrimaryCare ... #Rosacea #NEJM
Management of type 2 diabetes in adults: summary of updated NICE guidance #Management #IM #PrimaryCare #Endo
guidance #Management #IM ... #PrimaryCare #Endo
Hemolysis in Hereditary Spherocytosis. Panel A shows the structure of a normal red cell and a
Pathophysiology #Honc ... #IM #Spherocytosis ... HereditarySpherocytosis #NEJM
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
Pathophysiology #IM ... #Honc #Pharm #GVHD ... Immunosuppression #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
and Secondary End ... Points #EBM #Neuro #IM ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM